Yahoo Web Search

  1. In that same time, the Medical sector gained 7.46%, while the S&P 500 gained 7.86%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.27 billion, down 9.15% from ...

  2. Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $8.89, moving +0.91% from the previous trading session. This move outpaced ...

  3. Teva's Migraine Prevention Drug Meets Exploratory Endpoints

    Benzinga via Yahoo FinanceJul 02 14:29 PM

    Teva Pharmaceutical Industries Ltd (NYSE: TEVA) announced trial results Tuesday that could bode well for migraine patients. At the Fifth Congress of the European ...

  4. Shares of Teva Pharmaceutical Industries Ltd. TEVA fell almost 7.5% on Jul 15, following media reports of a rating downgrade by an analyst at Morgan Stanley ...

  5. AstraZeneca Plc AZN announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for label expansion of its diabetes drug ...

  6. Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the European Commission (EC) has granted conditional marketing authorization to skin cancer drug, Libtayo. The ...

  7. Bulls And Bears Of The Week: Apple, Nike, Tesla, Uber And More

    Benzinga via Yahoo FinanceJul 06 19:04 PM

    The following are just a few of the past week's most bullish and bearish posts that may be worth another look. "Analyst: The G-20 Winner 'Is Clearly Apple'" by Wayne Duggan details why Apple ...

  8. NASDAQ: MSON) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Morphic Holding Inc (NASDAQ: MORF)(IPOed June 27) Odonate Therapeutics Inc (NASDAQ: ODT) Ra Pharmaceuticals ...

  9. Oklahoma judge denies motion to end case against drugmaker

    Associated Press via Yahoo FinanceJul 08 20:21 PM

    The defendants filed the motion last week after the state rested its case. Company attorneys had argued the state's case is an inappropriate use of a public-nuisance claim , typically reserved ...

  10. Teva Pharmaceutical Industries Ltd (NYSE: TEVA) downgraded from Equal-Weight to Underweight, price target lowered from $16 to $6.

  1. Ads
    related to TEVA Pharmaceutical Industries Ltd